6-105078551-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001004317.4(LIN28B):c.521C>T(p.Ala174Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001004317.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIN28B | NM_001004317.4 | c.521C>T | p.Ala174Val | missense_variant | 4/4 | ENST00000345080.5 | |
LIN28B | NM_001410939.1 | c.545C>T | p.Ala182Val | missense_variant | 5/5 | ||
LIN28B | XM_006715477.3 | c.578C>T | p.Ala193Val | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIN28B | ENST00000345080.5 | c.521C>T | p.Ala174Val | missense_variant | 4/4 | 1 | NM_001004317.4 | P1 | |
LIN28B | ENST00000637759.1 | c.545C>T | p.Ala182Val | missense_variant | 5/5 | 5 | |||
LIN28B | ENST00000635857.1 | c.578C>T | p.Ala193Val | missense_variant | 6/6 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000329 AC: 5AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251280Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135796
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727242
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74384
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at